Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is a publicly traded the market company. As of August 14, 2026, DMII trades at $10.10 with a market cap of $644.01M and a P/E ratio of 0.00. DMII moved +0.00% today. Year to date, DMII is +2.43%; over the trailing twelve months it is flat. Its 52-week range spans $9.86 to $10.20. Rallies surfaces DMII's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DMII moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $10.10 |
| Market Cap | $644.01M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.20 |
| 52-Week Low | $9.86 |
| Volume | 6 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $4.19M |
| Gross Margin | 0.00% |
DMII analyst coverage data. Average price target: $0.00.